Financhill
Sell
41

HQY Quote, Financials, Valuation and Earnings

Last price:
$95.76
Seasonality move :
0.93%
Day range:
$94.92 - $104.20
52-week range:
$74.07 - $116.65
Dividend yield:
0%
P/E ratio:
57.92x
P/S ratio:
6.67x
P/B ratio:
3.81x
Volume:
1.6M
Avg. volume:
842.3K
1-year change:
-7.12%
Market cap:
$8.2B
Revenue:
$1.2B
EPS (TTM):
$2.18

Analysts' Opinion

  • Consensus Rating
    HealthEquity, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $121.14, HealthEquity, Inc. has an estimated upside of 26.63% from its current price of $95.67.
  • Price Target Downside
    According to analysts, the lowest downside price target is $100.00 representing -4.53% downside risk from its current price of $95.67.

Fair Value

  • According to the consensus of 10 analysts, HealthEquity, Inc. has 26.63% upside to fair value with a price target of $121.14 per share.

HQY vs. S&P 500

  • Over the past 5 trading days, HealthEquity, Inc. has underperformed the S&P 500 by -8.98% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • HealthEquity, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • HealthEquity, Inc. has grown year-over-year revenues for 18 quarters straight. In the most recent quarter HealthEquity, Inc. reported revenues of $322.2M.

Earnings Growth

  • HealthEquity, Inc. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter HealthEquity, Inc. reported earnings per share of $0.59.
Enterprise value:
8.9B
EV / Invested capital:
--
Price / LTM sales:
6.67x
EV / EBIT:
29.67x
EV / Revenue:
7.03x
PEG ratio (5yr expected):
1.54x
EV / Free cash flow:
28.50x
Price / Operating cash flow:
27.03x
Enterprise value / EBITDA:
19.49x
Gross Profit (TTM):
$793.2M
Return On Assets:
4.2%
Net Income Margin (TTM):
11.49%
Return On Equity:
6.84%
Return On Invested Capital:
4.49%
Operating Margin:
27.89%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-10-31 2024-10-31 2025-10-31 2024-10-31 2025-10-31
Income Statement
Revenue $971M $1.2B $1.3B $300.4M $322.2M
Gross Profit $498.7M $643.4M $793.2M $168.7M $201.1M
Operating Income $105.3M $199.7M $326.6M $54.1M $79.9M
EBITDA $260.9M $360.9M $481.8M $94.8M $118.6M
Diluted EPS $0.34 $1.10 $2.18 $0.06 $0.59
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Balance Sheet
Current Assets $764.1M $332.2M $474.4M $495.2M $498.7M
Total Assets $3.1B $3.1B $3.1B $3.5B $3.4B
Current Liabilities $107.1M $110.4M $96.2M $154.5M $120.6M
Total Liabilities $1.2B $1.2B $1.1B $1.4B $1.3B
Total Equity $1.9B $1.9B $2B $2.1B $2.1B
Total Debt $1B $987.5M $924.9M $1.1B --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-10-31 2024-10-31 2025-10-31 2024-10-31 2025-10-31
Cash Flow Statement
Cash Flow Operations $221.2M $341.2M $414.9M $90.6M $138.6M
Cash From Investing -$45.1M -$503.2M -$52.3M -$12.9M -$11.4M
Cash From Financing -$52.3M $150.1M -$375.6M -$82.4M -$122.4M
Free Cash Flow $176.2M -$162M -- $77.7M --
HQY
Sector
Market Cap
$8.2B
$28.4M
Price % of 52-Week High
82.02%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
2.59%
-1.32%
1-Year Price Total Return
-7.12%
-22.19%
Beta (5-Year)
0.176
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $101.86
200-day SMA
Buy
Level $95.35
Bollinger Bands (100)
Buy
Level 90.24 - 98.88
Chaikin Money Flow
Buy
Level 72.2M
20-day SMA
Sell
Level $100.59
Relative Strength Index (RSI14)
Sell
Level 41.39
ADX Line
Sell
Level 21.3
Williams %R
Buy
Level -93.2065
50-day SMA
Sell
Level $96.25
MACD (12, 26)
Buy
Level 1.08
25-day Aroon Oscillator
Buy
Level 52
On Balance Volume
Neutral
Level 116.8M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (4.7561)
Buy
CA Score (Annual)
Level (0.4937)
Buy
Beneish M-Score (Annual)
Level (-2.7443)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-1.1858)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

HealthEquity, Inc. engages in the provision of technology-enabled services for healthcare and spending decisions. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

Stock Forecast FAQ

In the current month, HQY has received 8 Buy ratings 2 Hold ratings, and 0 Sell ratings. The HQY average analyst price target in the past 3 months is $121.14.

  • Where Will HealthEquity, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that HealthEquity, Inc. share price will rise to $121.14 per share over the next 12 months.

  • What Do Analysts Say About HealthEquity, Inc.?

    Analysts are divided on their view about HealthEquity, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that HealthEquity, Inc. is a Sell and believe this share price will drop from its current level to $100.00.

  • What Is HealthEquity, Inc.'s Price Target?

    The price target for HealthEquity, Inc. over the next 1-year time period is forecast to be $121.14 according to 10 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.

  • Is HQY A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for HealthEquity, Inc. is a Buy. 8 of 10 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of HQY?

    You can purchase shares of HealthEquity, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase HealthEquity, Inc. shares.

  • What Is The HealthEquity, Inc. Share Price Today?

    HealthEquity, Inc. was last trading at $95.76 per share. This represents the most recent stock quote for HealthEquity, Inc.. Yesterday, HealthEquity, Inc. closed at $95.67 per share.

  • How To Buy HealthEquity, Inc. Stock Online?

    In order to purchase HealthEquity, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Sell
44
PSTG alert for Dec 5

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
15
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.

Buy
69
ASTS alert for Dec 5

AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock